NCT04895644

Brief Summary

The Duration of External Neck Stabilisation (DENS) study is a randomised controlled trial comparing early removal of a hard collar with treatment in a hard collar for 12 weeks in older or frail adults with odontoid (dens) fractures. The primary outcome measure is QoL assessed using the EQ-5D-5L at 12 weeks following injury. The aim of the study is to determine whether management without a collar improves outcome, compared to management with a collar. Cost efficiency will be assessed over the observed 6 months using standard NICE reference case methodology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 20, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

November 18, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2.5 years

First QC Date

March 31, 2021

Last Update Submit

September 16, 2024

Conditions

Keywords

ElderlyHard CollarDensOdontoid

Outcome Measures

Primary Outcomes (1)

  • EQ-5D-5L Score - (EuroQol five dimensional descriptive system)

    Primary Outcome is Quality of Life assessed using the EQ-5D-5L questionnaire at 12 weeks post injury. EQ-5D-5L - Is the EuroQol 5D-5L a descriptive system that comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

    12 weeks

Secondary Outcomes (15)

  • EQ-5D-5L Score - (EuroQol five dimensional descriptive system)

    Measured at 2 and 6 weeks and 6 months post injury

  • Neck Disability Index (NDI)

    Measured at 2, 6 and 12 weeks and 6 months post injury

  • Numeric Pain Rating Scale (NPRS)

    Measured at 2, 6 and 12 weeks and 6 months post injury

  • Mortality

    6 months post injury

  • Adverse events

    Up to 12 weeks post injury

  • +10 more secondary outcomes

Study Arms (2)

No Hard Collar

EXPERIMENTAL

Patient randomised to not wearing a Hard Collar for 12 weeks

Other: No Hard Collar

Standard Care Arm - Hard Collar

NO INTERVENTION

Patient randomised to wearing a Hard Collar for 12 weeks - standard care

Interventions

The patient in the intervention arm will not wear a Hard Collar for 12 weeks post injury

No Hard Collar

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Rockwood clinical frailty scale (CFS) of 5 or more, or aged 65 years or over;
  • A recent odontoid fracture (type I-III) (within 3 weeks) as assessed on CT, irrespective of degree of fracture angulation, displacement or canal narrowing;
  • History of recent trauma (within 3 weeks)
  • Determined by spinal consultant (or delegated registrar) as suitable for standard care 12-week treatment with hard collar and for randomisation to treatment without a collar
  • Recruited within 3 weeks of injury

You may not qualify if:

  • New neurological deficit (numbness / weakness) attributable to fracture;
  • Assessed as unable to tolerate a hard collar e.g., dystonia, fixed deformity;
  • Additional (non-odontoid) cervical spine fracture not suitable for management without a hard collar;
  • Underlying condition potentially leading to spinal instability, e.g., ankylosing spondylitis, diffuse idiopathic skeletal hyperostosis (DISH);
  • Fracture suspected to be older than three weeks at the time of assessment;
  • Consultant spinal surgeon determines fracture requires surgical treatment or is otherwise unsuitable for non-surgical treatment with or without a hard collar;
  • If not expected to survive to hospital discharge based on concomitant injuries or illnesses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Infirmary of Edinburgh

Edinburgh, EH16 4SA, United Kingdom

Location

Related Publications (1)

  • Woodfield J, Edlmann E, Black PL, Boyd J, Copley PC, Cranswick G, Eborall H, Keerie C, Khan S, Lawton J, Lowe DJ, Norrie J, Niven A, Reed MJ, Shenkin SD, Statham P, Stoddart A, Tomlinson J, Brennan PM. Duration of External Neck Stabilisation (DENS) following odontoid fracture in older or frail adults: protocol for a randomised controlled trial of collar versus no collar. BMJ Open. 2022 Jul 15;12(7):e057753. doi: 10.1136/bmjopen-2021-057753.

Study Officials

  • Paul Brennan

    University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised Control Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2021

First Posted

May 20, 2021

Study Start

November 18, 2021

Primary Completion

May 31, 2024

Study Completion

June 10, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Anonymised patient-level data will be available on reasonable request to the Chief Investigator (paul.brennan@ed.ac.uk). The trial protocol and statistical analysis plans will be published and available prior to trial completion.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The Protocol (and consent form) has been submitted to the British Medical Journal - BMJ Open and will be available once their review is complete. The SAP will be available prior to trial completion.
Access Criteria
Available on reasonable request to the Chief Investigator (paul.brennan@ed.ac.uk) as assessed by the study management group

Locations